Prognostic impact of telomerase activity in non-small cell lung cancers

Annals of Surgery

Volumn 230, Issue 5, 1999, Pages 715-720

  Taga, Satoshi ^a   Osaki, Toshihiro ^a   Ohgami, Akira ^a   Imoto, Hideyuki ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TELOMERASE;

EID: 0033498902     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199911000-00015     Document Type: Article

References (34)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-573.
2. Zakian VA. structure and function of telomeres. Annu Rev Genet 1989; 23:579-604.
3. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence (TTAGGG) present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85:6622-6626.
4. Harley CB, Futcher AB, Grieder CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345:458-460.
5. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990; 346:866-868.
6. Levy MZ, Allsopp RC, Futcher AB, et al. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225:951-960.
7. Watson JD. Origin of concatemeric T7 DNA. Nature New Biol 1972; 239:197-201.
8. Olovnikov AM. A theory of marginotomy. J Theor Biol 1973; 41: 181-190.
9. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11:1921-1929.
10. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
11. Blackburn EH. Telomerases. Annu Rev Biochem 1995; 61:113-129.
12. Piatyszek MA, Kim SL, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods in Cell Science 1995; 17:1-15.
13. Taylor RS, Ramirez RD, Ogoshi M, et al. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106:759-765.
14. Hiyama E, Hiyama K, Tatsumoto N, et al. Telomerase activity in human intestine. Im J Oncol 1996; 9:453-458.
15. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155:3711-3715.
16. Hiyama E, Hiyama K, Yokoyama T, et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1:249-255.
17. Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55:2533-2536.
18. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55:3258-3262.
19. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res 1995; 55:2734-2736.
20. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:895-902.
21. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
22. Wright WE, Shay JW, Piatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity, and sensitivity. Nucleic Acids Res 1995; 23:3794-3795.
23. Shay JW, Werbin H, Wright WE. Telomeres and telomerase in human leukemias. Leukemia 1996; 10:1255-1261.
24. Nakashio R, Kitamoto M, Tahara H, et al. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Im J Cancer 1997; 74:141-147.
25. Sugio K, Ishida T, Yokoyama H, et al. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992; 52:2903-2906.
26. Kern J, Slebos R, Top B, et al. c-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J Clin Invest 1994; 93:516-520.
27. Nishio M, Koshikawa T, Kuroishi T, et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol 1996; 14:497-502.
28. Mitsudomi T, Oyama T, Nishida K, et al. p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival. Ann Oncol 1995; 6(Suppl 3):S9-S13.
29. Mitsudomi T, Oyama T, Kusano T, et al. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst 1993; 85:2018-2023.
30. Isida T, Kaneko S, Akazawa K, et al. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 1993; 53:5000-5003.
31. Mitsudomi T, Oyama T, Nishida K, et al. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin Cancer Res 1996; 2:1185-1189.
32. INK4 expression in nonsmall cell lung carcinoma. Cancer 1997; 80:389-395.
33. Kishimoto Y, Sugio K, Mitsudomi T, et al. Frequent loss of the short arm of chromosome 9 in resected non-small cell lung cancers from Japanese patients and its association with squamous cell carcinoma. J Cancer Res Clin Oncol 1995; 121:291-296.
34. Imoto H, Osaki T, Taga S, et al. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 1998; 115:1007-1014.